Cyclosporine improves results in HLA-identical sibling renal transplants.
Van Buren
D
D
Vanderbilt University Medical Center, Nashville, TN 37232-4750.
MacDonell
R
R
Johnson
H K
HK
Richie
R
R
Ynares
C
C
Helderman
J H
JH
Green
W
W
Crowe
D
D
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D015331:Cohort Studies; D016572:Cyclosporine / Q000627:therapeutic use*; D004200:Diseases in Twins; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate; D013997:Time Factors; D014430:Twins, Monozygotic
D000961:Antilymphocyte Serum; D006680:HLA Antigens; D016572:Cyclosporine